Amarin Corporation plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AMRN | YPH.F | 4552.T | NVS | AZN | NAVA.OL | |
|---|---|---|---|---|---|---|
| Market cap | 515.02M | 26.36B | 64.55B | 311.59B | 293.14B | 247.01M |
| P/E (TTM) | — | 13.0 | — | 31.5 | 26.7 | — |
| Forward P/E | 12.5 | — | 14.4 | 16.6 | 16.7 | 22.1 |
| Price/book | 0.6 | 2.4 | 1.6 | 8.4 | 5.7 | 0.9 |
| Dividend yield | — | 3.17% | 3.97% | 2.87% | 1.69% | — |
| 1-year change | −21.29% | +51.13% | −17.24% | +30.35% | +12.81% | −50.71% |
| Today | +1.66% | +5.76% | +4.96% | +3.59% | +2.79% | −2.83% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All AMRN news ›Amarin expects U.S. volumes to remain stable through 2026 while Europe demand rises 68%
Amarin Q3 2026 earnings: profit returns, cash grows, and VASCEPA expansion continues despite pricing pressure. Earnings Call Insights: Amarin (AMRN) Q3 2026 - "As we approach the end of the year" CEO, President & Director Aaron Berg said…
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
Global Commercial Momentum and Continued U.S. Market Leadership Licensing and royalty revenue in Q3 2026 rose 139% to $2.7 million and reflected increased partner sales within their respective territories. COGS: Decreased 15% to $23.4…
Amarin Corporation plc (AMRN) Q3 2026 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Aaron Berg - CEO, President & DirectorPeter Fishman - Senior VP & CFOSteven Ketchum - Executive VP, President of Research & Development and Chief Scientific…
Amarin announces EPA for Metastasis Trial 2 did not meet primary endpoint
Amarin (AMRN) highlighted findings from the EPA for Metastasis Trial 2, EMT2, a randomized, double-blind, placebo-controlled, multi-center, Phas... Amarin announces EPA for Metastasis Trial 2 did not meet primary endpoint Amarin (AMRN)…
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in...
Pre-specified and Statistically Powered Key Endpoints Included Progression-free Survival (PFS) and Overall Survival (OS). Although Primary Endpoint of PFS Was Not Met, The Key Secondary Endpoint of OS Was Improved With VAZKEPA/VASCEPA…
Amarin (NASDAQ:AMRN) and Organon & Co. (NYSE:OGN) Critical Contrast
Posted by Sarita Garza on Oct 28th, 2026 Amarin (NASDAQ:AMRN – Get Free Report) and Organon & Co. (NYSE:OGN – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on…
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
Information on how to participate is as follows. Access to the live call: Via online: A webcast of the call will be available on the Investor Relations section of the Company's website at www.amarincorp.com. Access to the replay: Via…
Amarin (NASDAQ:AMRN) and Merck KGaA (OTCMKTS:MKKGY) Financial Review
Posted by Mitch Edgeman on Oct 11th, 2026 Merck KGaA (OTCMKTS:MKKGY – Get Free Report) and Amarin (NASDAQ:AMRN – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based…
Gaysorn Amarin showcases prize watches ahead of Geneva show
PUBLISHED : 6 Oct 2026 at 01:01 Bangkok has been selected as one of only four global destinations to host the Grand Prix d'Horlogerie de Genève (GPHG) Nomination Tour 2026, at The Forum of Gaysorn Amarin, Phloenchit Road, from Oct 15-18.…
Amarin’s Q3 revenue drops amid U.S. pricing pressure
Amarin Q3 earnings: revenue fell 20%, but lower costs, positive free cash flow, and rising global VASCEPA demand highlight improving financial strength. - Amarin press release (AMRN): Q3 Non-GAAP EPADS of $0.08. Operating expenses: $18.5M,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com5
- markets.businessinsider.com2
- themarketsdaily.com2
- manilatimes.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.